AWM
ABEO icon

Activest Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

Activest Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-120
Closed -$761 – 1146
2025
Q2 		$682 Hold
120
– – ﹤0.01% 823
2025
Q1 		$571 Hold
120
– – ﹤0.01% 838
2024
Q4 		$668 Hold
120
– – ﹤0.01% 500
2024
Q3 		$758 Hold
120
– – ﹤0.01% 472
2024
Q2 		$509 Buy
+120
New +$612 ﹤0.01% 460

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Activest Wealth Management's ABEO Position: Q3 2025 in Review

Activest Wealth Management sold out of Abeona Therapeutics (ABEO) in Q3 2025, closing a stake of 120 shares — an estimated $761 sold.

Activest Wealth Management first reported a position in ABEO in Q2 2024 and held it in 5 quarters. The position peaked at $758 in Q3 2024. 100 funds tracked by Wall St. Rank hold ABEO as of Q3 2025.

  • Activest Wealth Management reported no remaining Abeona Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Activest Wealth Management sold 120 Abeona Therapeutics shares in Q3 2025, an estimated $761.
  • Activest Wealth Management first reported a position in Abeona Therapeutics in Q2 2024 and held it in 5 quarters.
  • Activest Wealth Management's Abeona Therapeutics position peaked at $758 in Q3 2024.
  • 100 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2025.

Based on Activest Wealth Management's 13F filing for Q3 2025, filed 3 Nov 2025.